MX2012014629A - Composicion farmaceutica que comprende drospirenona y kit anticonceptivo. - Google Patents

Composicion farmaceutica que comprende drospirenona y kit anticonceptivo.

Info

Publication number
MX2012014629A
MX2012014629A MX2012014629A MX2012014629A MX2012014629A MX 2012014629 A MX2012014629 A MX 2012014629A MX 2012014629 A MX2012014629 A MX 2012014629A MX 2012014629 A MX2012014629 A MX 2012014629A MX 2012014629 A MX2012014629 A MX 2012014629A
Authority
MX
Mexico
Prior art keywords
drospirenone
pharmaceutical composition
contraceptive kit
present
contraceptive
Prior art date
Application number
MX2012014629A
Other languages
English (en)
Other versions
MX339952B (es
Inventor
Philippe Perrin
Jose Velada
Dominique Drouin
Original Assignee
Leon Farma Sa Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48802149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2012014629(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leon Farma Sa Lab filed Critical Leon Farma Sa Lab
Priority claimed from PCT/EP2011/060795 external-priority patent/WO2012000981A1/en
Publication of MX2012014629A publication Critical patent/MX2012014629A/es
Publication of MX339952B publication Critical patent/MX339952B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere al campo de las composiciones farmacéuticas y métodos anticonceptivos. La presente invención proporciona una composición famacéutica que comprende drospirenona caracterizada por un intervalo de disolución lento de drospirenona in vitro y un perfil farmacocinético y mejorado. El uso de este compuesto en métodos anticonceptivos y kits también es proporcionado.
MX2012014629A 2010-06-29 2011-06-28 Composicion farmaceutica que comprende drospirenona y kit anticonceptivo. MX339952B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10305708 2010-06-29
US36839610P 2010-07-28 2010-07-28
PCT/EP2011/060795 WO2012000981A1 (en) 2010-06-29 2011-06-28 Pharmaceutical composition comprising drospirenone and contraceptive kit

Publications (2)

Publication Number Publication Date
MX2012014629A true MX2012014629A (es) 2013-05-06
MX339952B MX339952B (es) 2016-06-20

Family

ID=48802149

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2012014629A MX339952B (es) 2010-06-29 2011-06-28 Composicion farmaceutica que comprende drospirenona y kit anticonceptivo.
MX2015008884A MX364971B (es) 2010-06-29 2011-06-28 Composicion farmaceutica que comprende drospirenona y kit anticonceptivo.
MX2019004393A MX2019004393A (es) 2010-06-29 2012-12-13 Composicion farmaceutica que comprende drospirenona y kit anticonceptivo.

Family Applications After (2)

Application Number Title Priority Date Filing Date
MX2015008884A MX364971B (es) 2010-06-29 2011-06-28 Composicion farmaceutica que comprende drospirenona y kit anticonceptivo.
MX2019004393A MX2019004393A (es) 2010-06-29 2012-12-13 Composicion farmaceutica que comprende drospirenona y kit anticonceptivo.

Country Status (14)

Country Link
KR (1) KR102210982B1 (es)
BR (1) BR122019008317A2 (es)
CL (1) CL2012003685A1 (es)
CO (1) CO6640328A2 (es)
DK (1) DK2588114T3 (es)
EC (3) ECSP12012359A (es)
ES (1) ES2777886T3 (es)
GT (3) GT201200336BA (es)
HR (1) HRP20200155T1 (es)
HU (1) HUE047689T2 (es)
LT (2) LT2588114T (es)
MX (3) MX339952B (es)
PT (1) PT2588114T (es)
ZA (1) ZA201209743B (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009138224A1 (en) * 2008-05-14 2009-11-19 Helm Ag Pharmaceutical composition comprising drospirenone

Also Published As

Publication number Publication date
MX2019004393A (es) 2019-09-09
KR102210982B1 (ko) 2021-02-02
MX364971B (es) 2019-05-16
HRP20200155T1 (hr) 2020-05-01
BR122019008317A2 (pt) 2020-09-29
ECSP12012359A (es) 2013-03-28
HUE047689T2 (hu) 2020-05-28
CL2012003685A1 (es) 2013-07-05
MX339952B (es) 2016-06-20
LT2588114T (lt) 2020-02-25
ECSP15032911A (es) 2016-01-29
ES2777886T3 (es) 2020-08-06
DK2588114T3 (da) 2020-02-17
GT201200336AA (es) 2017-10-23
ECSP15032906A (es) 2016-01-29
PT2588114T (pt) 2020-02-20
ZA201209743B (en) 2014-03-26
KR20190073598A (ko) 2019-06-26
GT201200336BA (es) 2017-10-23
GT201200336A (es) 2014-01-14
LTPA2021523I1 (es) 2021-11-10
CO6640328A2 (es) 2013-03-22

Similar Documents

Publication Publication Date Title
HUS2000016I1 (hu) Drospirenont és fogamzásgátló kitet tartalmazó gyógyászati készítmény
MX359639B (es) Metodos y composiciones para uso en tratamientos celulares.
MX2015002056A (es) Composiciones de cemento de geopolimeros y metodos de uso.
TN2011000656A1 (en) Pharmaceutical composition for emergency contraception
TN2012000161A1 (en) Spiro-oxindole mdm2 antagonists
MX2019000225A (es) Composiciones y metodos para el tratamiento de enfermedades autoinmunes y otras enfermedades.
IL214822A0 (en) Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
ZA201100605B (en) Micronised progesterone pharmaceutical composition and uses thereof
MX2013001677A (es) Formulaciones estables de linaclotida.
MX2013002784A (es) Heteroarilos fusionados y sus usos.
ZA201403431B (en) Pharmaceutical compositions and methods of use of 4-pregenen-11b-21-triol-3,20-dione derivatives
EP2635260A4 (en) COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS
HK1142608A1 (en) 5-pyridinone substituted indazoles and pharmaceutical compositions thereof 5-
MX2012010127A (es) Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
PH12014500714A1 (en) Stable sns-595 compositions and methods of preparation
EP2568810A4 (en) COMPOSITIONS OF DARUNAVIR
IN2015DN04074A (es)
MX2019004393A (es) Composicion farmaceutica que comprende drospirenona y kit anticonceptivo.
GB201405031D0 (en) Storage stable premixed hydraulic cement compositions, cements, methods, and articles
ZA201105443B (en) Novel saponin compounds,methods of preparation thereof,use thereof and pharmaceutical compositions
UA59396U (ru) Применение композиций нестероидных противовоспалительных средств с кофеином как препаратов с антиэкссудативной активностью

Legal Events

Date Code Title Description
FG Grant or registration